Author： Olver Ian N
Publisher： Future Medicine
ISSN： 1479-6694
Source： Future Oncology, Vol.4, Iss.1, 2008-02, pp. : 125-131
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Trastuzumab in the treatment of advanced breast cancer: Single-center experience
By Mrsić M. Grgić M. SRC="/iso-ents/isolat2/cacute-s.gif" ALT="cacute" Z. Podolski P. Bogdanić V. Labar B. SRC="/iso-ents/isolat2/cacute-s.gif" ALT="cacute" J. Restek-Samaržija N. Gošev M.
![SRC="/iso-ents/isolat2/cacute-s.gif" ALT="cacute" Z.](/index/search?type=2&isAccurate=1&searchValue="SRC="/iso-ents/isolat2/cacute-s.gif" ALT="cacute" Z."){kind=link}
![SRC="/iso-ents/isolat2/cacute-s.gif" ALT="cacute" J.](/index/search?type=2&isAccurate=1&searchValue="SRC="/iso-ents/isolat2/cacute-s.gif" ALT="cacute" J."){kind=link}
Annals of Oncology, Vol. 12, Iss. 12, 2001-12 ,pp. :
Results from an observational trial with oral vinorelbine and trastuzumab in advanced breast cancer
By Bartsch Rupert Wenzel Catharina Altorjai Gabriela Pluschnig Ursula Bachleitner-Hoffmann Thomas Locker Gottfried Rudas Margaretha Mader Robert Zielinski Christoph Steger Guenther
Breast Cancer Research and Treatment, Vol. 102, Iss. 3, 2007-05 ,pp. :